Caplin Point Laboratories Ltd Stock NSE India S.E.
Stocks
INE475E01018
Pharmaceuticals
|
End-of-day quote
NSE India S.E.
|
||
| - INR | - |
|
| Aug. 14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| Aug. 12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 209B 2.18B 1.9B 1.79B 1.63B 3.05B 3.06B 21.47B 8.28B 106B 8.18B 8B 342B | P/E 2027 * |
28.7x | P/E 2028 * | 24.8x |
|---|---|---|---|---|---|
| Enterprise Value | 209B 2.18B 1.9B 1.79B 1.63B 3.05B 3.06B 21.47B 8.28B 106B 8.18B 8B 342B | EV / Sales 2027 * |
8.33x | EV / Sales 2028 * | 7.37x |
| Free-Float |
26.56% | Yield 2027 * |
0.15% | Yield 2028 * | 0.15% |
Last Transcript: Caplin Point Laboratories Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 71 | 2015-03-27 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 2016-02-18 |
Anto V.
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2010-01-26 | |
| Director/Board Member | - | 2025-11-04 | |
Sridhar Ganesan
BRD | Director/Board Member | 71 | 2015-03-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | -0.15% | +11.45% | +60.09% | 46.78B | |
| -1.02% | -1.90% | +35.99% | +100.50% | 37.88B | |
| +2.19% | +3.65% | +10.70% | +80.29% | 11.82B | |
| +1.32% | +2.09% | -11.64% | +12.41% | 11.61B | |
| -0.95% | 0.00% | +18.72% | +150.00% | 9.12B | |
| +0.39% | +2.39% | +29.99% | +38.63% | 7.38B | |
| -0.06% | +2.97% | +38.90% | -18.67% | 7.21B | |
| +1.30% | +1.17% | +16.08% | +187.41% | 7.12B | |
| +0.70% | +1.10% | -44.22% | +5.78% | 4.99B | |
| Average | +0.25% | +0.45% | +11.77% | +68.49% | 15.99B | |
| Weighted average by Cap. | -0.46% | -0.09% | +17.07% | +73.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 25.07B 261M 228M 215M 195M 366M 368M 2.58B 994M 12.75B 982M 960M 41.02B | 28.34B 295M 258M 243M 221M 414M 415M 2.91B 1.12B 14.41B 1.11B 1.08B 46.36B |
| Net income | 7.26B 75.71M 66.02M 62.34M 56.6M 106M 106M 747M 288M 3.69B 284M 278M 11.88B | 8.41B 87.66M 76.44M 72.17M 65.54M 123M 123M 865M 334M 4.28B 329M 322M 13.76B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
